JAK1 and neoplasm: Previous studies have shown that STT3A is recruited by phosphorylated PD-L1 under IL-6-JAK1 signaling and mediates its glycosylation, enhancing PD-L1 stability and facilitating tumor immune escape in hepatocellular carcinoma (50, 51).